Cytogenetics market is primarily driven by an increase in the prevalence of genetic disorders and cancer. In addition, rise in health care spending, increase in the prevelance of chronic diseases, and a favorable reimbursement scenario are expected to boost the expansion of the market in the coming years.

Source: Click here